20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Understanding MAO-B Inhibitors: The Science Behind Rasagiline Mesylate

Monoamine oxidase B (MAO-B) inhibitors represent a significant class of drugs in the management of Parkinson's disease, and Rasagiline Mesylate is a prominent example. Understanding the mechanism of action of these compounds is essential for researchers and healthcare professionals aiming to optimize treatment strategies.

MAO-B is an enzyme found in the brain that is responsible for breaking down neurotransmitters, particularly dopamine. Dopamine plays a crucial role in controlling movement, and its deficiency is a hallmark of Parkinson's disease. Rasagiline Mesylate functions by selectively and irreversibly inhibiting MAO-B. This inhibition prevents the degradation of dopamine, thereby increasing its availability in the synaptic cleft and helping to alleviate the motor symptoms such as rigidity, tremor, and bradykinesia (slowness of movement).

The efficacy of Rasagiline Mesylate is well-documented. It can be used as monotherapy in early Parkinson's disease or as an adjunct to levodopa therapy in later stages. When used with levodopa, it can help to reduce 'off' time, which is the period when Parkinson's symptoms are not adequately controlled. The benefits extend to improved motor control and potentially a delay in the need for higher doses of levodopa, which can mitigate some of its long-term side effects.

For those involved in the pharmaceutical supply chain, ensuring the consistent availability of high-purity Rasagiline Mesylate is vital. Sourcing this compound from reputable manufacturers who adhere to stringent quality control measures, such as those certified with GMP and ISO, guarantees that the product meets the necessary standards for therapeutic use. The ability to buy Rasagiline Mesylate in bulk from a reliable supplier in China, with confirmed purity levels, supports the continuous development and production of essential Parkinson's disease treatments.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Role of Rasagiline Mesylate in Nootropic Formulations

Next: Quality Assurance in Pharmaceutical Intermediates: Focus on Rasagiline Mesylate

All Rights Reserved